These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22949140)

  • 1. Hydroxyurea treatment of children with hemoglobin SC disease.
    Yates AM; Dedeken L; Smeltzer MP; Lebensburger JD; Wang WC; Robitaille N
    Pediatr Blood Cancer; 2013 Feb; 60(2):323-5. PubMed ID: 22949140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea therapy for pediatric patients with hemoglobin SC disease.
    Miller MK; Zimmerman SA; Schultz WH; Ware RE
    J Pediatr Hematol Oncol; 2001; 23(5):306-8. PubMed ID: 11464988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Luchtman-Jones L; Pressel S; Hilliard L; Brown RC; Smith MG; Thompson AA; Lee MT; Rothman J; Rogers ZR; Owen W; Imran H; Thornburg C; Kwiatkowski JL; Aygun B; Nelson S; Roberts C; Gauger C; Piccone C; Kalfa T; Alvarez O; Hassell K; Davis BR; Ware RE
    Am J Hematol; 2016 Feb; 91(2):238-42. PubMed ID: 26615793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Original Research: Use of hydroxyurea and phlebotomy in pediatric patients with hemoglobin SC disease.
    Summarell CC; Sheehan VA
    Exp Biol Med (Maywood); 2016 Apr; 241(7):737-44. PubMed ID: 26993671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activity of superoxide dismutase in hydroxyurea-treated E beta thalassemia.
    Ajanta H; Chakraborty S; Madhusnata D; Bhattacharya DK; Manisha D
    J Assoc Physicians India; 2002 Aug; 50():1034-5. PubMed ID: 12421025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxyurea and other agents stimulating synthesis of fetal hemoglobin].
    de Montalembert M
    Pathol Biol (Paris); 1999 Jan; 47(1):55-8. PubMed ID: 10081780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K; Smith-Whitley K
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness and acceptance of hydroxyurea in the treatment of severe forms of sickle cell disease: a prospective study of 65 cases].
    Mellouli F; Chouaibi S; Dhouib N; Ouederni M; Ben Khaled M; Abbes S; Bejaoui M
    Tunis Med; 2013; 91(8-9):544-50. PubMed ID: 24227514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
    Stallworth JR; Jerrell JM; Tripathi A
    Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi-centre CHAMPS trial.
    Wang W; Brugnara C; Snyder C; Wynn L; Rogers Z; Kalinyak K; Brown C; Qureshi A; Bigelow C; Neumayr L; Smith-Whitley K; Chui DH; Delahunty M; Woolson R; Steinberg M; Telen M; Kesler K
    Br J Haematol; 2011 Mar; 152(6):771-6. PubMed ID: 21275961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers.
    Madden NA; Jones GL; Kalpatthi R; Woods G
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e382-6. PubMed ID: 24714503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low fixed-dose hydroxyurea in severely affected Indian children with sickle cell disease.
    Jain DL; Sarathi V; Desai S; Bhatnagar M; Lodha A
    Hemoglobin; 2012; 36(4):323-32. PubMed ID: 22734586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea therapy in 49 patients with major beta-thalassemia.
    Zamani F; Shakeri R; Eslami SM; Razavi SM; Basi A
    Arch Iran Med; 2009 May; 12(3):295-7. PubMed ID: 19400608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
    Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
    J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum urine concentrating ability in children with Hb SC disease: effects of hydroxyurea.
    Iyer R; Baliga R; Nagel RL; Brugnara C; Kirchner K; Hogan S; Steinberg MH
    Am J Hematol; 2000 May; 64(1):47-52. PubMed ID: 10815787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxyurea in children: present and future.
    Vichinsky EP
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):22-9. PubMed ID: 9317198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea in sickle cell disease patients from Eastern Saudi Arabia.
    Al-Jam'a AH; Al-Dabbous IA
    Saudi Med J; 2002 Mar; 23(3):277-81. PubMed ID: 11938415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal hemoglobin response to hydroxyurea in Yemeni sickle cell disease patients.
    Al-Nood HA; Al-Khawlani MM; Al-Akwa A
    Hemoglobin; 2011; 35(1):13-21. PubMed ID: 21250877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and hematological profile in a newborn cohort with hemoglobin SC.
    Rezende PV; Santos MV; Campos GF; Vieira LLM; Souza MB; Belisário AR; Silva CM; Viana MB
    J Pediatr (Rio J); 2018; 94(6):666-672. PubMed ID: 29195085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.